Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European decision could give longer patent protection worth €billions to companies

This article was originally published in Scrip

Executive Summary

Companies operating in Europe could stand to dramatically increase their revenues if the Court of Justice of the European Union (CJEU) upholds yesterday's opinion from one of its advocate generals, Yves Bot, on allowing negative term supplementary protection certificates (SPCs). A green light for such SPCs would pave the way for companies to benefit from longer patent protection in every EU country.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC013261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel